Evidence map›Paper›PMID 41003222›Full record

ArticleJournal of fungi (Basel, Switzerland)2025

National Belgian Study on Terbinafine Resistance in

Rosalie Sacheli, Sabrina Egrek, Khalid El Moussaoui, Bahoz Kurt, Emilie Machowski, Saadia Harag, Marie-Pierre Hayette

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of fungi (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rosalie SacheliClinical Microbiology Department, National Reference Center for Mycoses, Center for Interdisciplinary Research on Medicines, University Hospital of Liège, 4000 Liege, Belgium.ORCID 0000-0002-3922-324X
Sabrina EgrekClinical Microbiology Department, National Reference Center for Mycoses, Center for Interdisciplinary Research on Medicines, University Hospital of Liège, 4000 Liege, Belgium.ORCID 0000-0002-3825-7560
Khalid El MoussaouiClinical Microbiology Department, National Reference Center for Mycoses, Center for Interdisciplinary Research on Medicines, University Hospital of Liège, 4000 Liege, Belgium.ORCID 0009-0009-3317-377X
Bahoz KurtClinical Microbiology Department, National Reference Center for Mycoses, Center for Interdisciplinary Research on Medicines, University Hospital of Liège, 4000 Liege, Belgium.
Emilie MachowskiClinical Microbiology Department, National Reference Center for Mycoses, Center for Interdisciplinary Research on Medicines, University Hospital of Liège, 4000 Liege, Belgium.
Saadia HaragDermatopathology Department, University Hospital of St Pierre, 1000 Brussels, Belgium.
Marie-Pierre HayetteClinical Microbiology Department, National Reference Center for Mycoses, Center for Interdisciplinary Research on Medicines, University Hospital of Liège, 4000 Liege, Belgium.ORCID 0000-0002-9025-6493

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

dermatophytesepidemiologysqualene epoxidaseterbinafine resistanceTrichophyton indotineaeTrichophyton mentagrophytes type VII

Identifiers

PMID41003222
PMCPMC12470705

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.